GDF11 and early-onset autosomal dominant Alzheimer disease: Furthermore, treatment with recombinant GDF11 proteins was shown to promote neurogenesis and angiogenesis in mouse and rat models of stroke103,104 and in a mouse model of Alzheimer’s disease, revealing GDF11 as a potential therapeutic option for neurodegenerative disorders105.